Henlius Reports Revenue Rise For First Quarter Of 2024

The Company’s Core Products Showed Growth Compared To Last Year

Q1 1st First Quarter
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products